RegenMedTX Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

RegenMedTX General Information

Description

Developer of cell therapies for chronic kidney disease. The company develops cell therapy products that are programmed in the body to restore damaged kidney tissues by engrafting into, repairing or replacing damaged tissues or organ.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 3929 Westpoint Boulevard
  • Suite G
  • Winston-Salem, NC 27103
  • United States
+1 (336)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 3929 Westpoint Boulevard
  • Suite G
  • Winston-Salem, NC 27103
  • United States
+1 (336)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RegenMedTX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Mar-2016 Completed Startup
1. Seed Round 05-Aug-2015 Completed Startup
To view RegenMedTX’s complete valuation and funding history, request access »

RegenMedTX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cell therapies for chronic kidney disease. The company develops cell therapy products that are programmed i
Biotechnology
Winston-Salem, NC

Oslo, Norway
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

RegenMedTX Competitors (3)

One of RegenMedTX’s 3 competitors is Nextera, a Venture Capital-Backed company based in Oslo, Norway.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nextera Venture Capital-Backed Oslo, Norway
Akebia Therapeutics Formerly VC-backed Cambridge, MA
Genentech Formerly VC-backed South San Francisco, CA
You’re viewing 3 of 3 competitors. Get the full list »

RegenMedTX Patents

RegenMedTX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2010319385-A1 Rational design of regenerative medicine products Inactive 12-Nov-2009
JP-2016187640-A Tissue engineering scaffolds Inactive 14-Feb-2008

RegenMedTX Investments & Acquisitions (2)

RegenMedTX’s most recent deal was a Secondary Transaction - Private with Tengion. The deal was made on 01-Nov-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Tengion 01-Nov-2017 Secondary Transaction - Private Biotechnology
Tengion 06-Mar-2015 Merger/Acquisition Biotechnology
To view RegenMedTX’s complete investments and acquisitions history, request access »

RegenMedTX FAQs

  • When was RegenMedTX founded?

    RegenMedTX was founded in 2014.

  • Where is RegenMedTX headquartered?

    RegenMedTX is headquartered in Winston-Salem, NC.

  • What industry is RegenMedTX in?

    RegenMedTX’s primary industry is Biotechnology.

  • Is RegenMedTX a private or public company?

    RegenMedTX is a Private company.

  • What is RegenMedTX’s current revenue?

    The current revenue for RegenMedTX is .

  • How much funding has RegenMedTX raised over time?

    RegenMedTX has raised $4.37M.

  • Who are RegenMedTX’s competitors?

    Nextera, Akebia Therapeutics, and Genentech are competitors of RegenMedTX.

  • When was RegenMedTX acquired?

    RegenMedTX was acquired on 01-Mar-2016.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »